Returning to work after blood cancer treatment
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study helps people who have finished treatment for a blood cancer (like leukemia or lymphoma) figure out the best way to return to work. It looks at what support might be needed during this transition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of blood cancer that is under control after treatment
- You have finished your main chemotherapy (maintenance therapy is okay)
- You are between 18 and 55 years old
- You worked for at least 6 months in the 2 years before your cancer diagnosis
- You have not yet returned to work since your diagnosis
- You agree to take part and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a structured “end-of-treatment” day hospital program to improve quality of life for adolescents and young adults after cancer treatment. You may be offered follow-up and supportive care soon after finishing treatment to help you feel better physically and emotionally.
This study looks at whether a simple blood test can help predict how well a person with a blood cancer like leukemia, lymphoma, or multiple myeloma might do. It aims to find a new biomarker that could guide treatment decisions.
This study tests whether a tailored coaching program can help people with non-metastatic breast cancer return to work in a way that fits their physical and emotional needs. It’s for people who have finished most cancer treatments and are dealing with job-related difficulties.
This study connects people with cancer to employment support services. It aims to help you keep or return to work while managing your cancer care.
This study offers help and support for people who had a stem cell transplant from a donor in the last six months and are worried about returning to work. It is designed to address your concerns and help you get back to your job.
This study asks Italian employers about their experience helping an employee with cancer return to work. It aims to understand what helps and what makes the process difficult.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.